Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2024-09-27 AGM Information
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is announcing the 'Result of AGM' (Annual General Meeting) held on September 26th, confirming that 'all resolutions were duly passed.' This directly corresponds to the definition of AGM Information (AGM-R). Although it is a result announcement, the core subject matter is the outcome of the AGM, making AGM-R the most specific classification over a general Regulatory Filing (RNS) or a general voting result announcement (DVA), as the context is clearly the Annual General Meeting.
2024-09-27 English
Posting of Annual Report and Notice of AGM
AGM Information Classification · 1% confidence The document is a short announcement (2391 characters) released via RNS (RNS Number: 6540A) on August 15, 2024. The title explicitly states 'Posting of Annual Report and Notice of AGM'. The text confirms that the 'Annual Report and Accounts for the year ended 31 March 2024' and the 'Notice of Annual General Meeting' have been posted to shareholders and will be made available on the website. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report, rather than containing the full report itself, should be classified as a Report Publication Announcement (RPA). Although it mentions the AGM and Annual Report, the primary action described is the *announcement* of their posting.
2024-08-15 English
Directorate Change
Board/Management Information Classification · 1% confidence The document is an official announcement filed via RNS (Regulatory Information Service) on August 13, 2024. The core content explicitly details a change in senior management: the Chief Operating Officer (James Cooper) is appointed interim CEO, and the current CEO (Jag Grewal) has resigned and stepped down from the Board. This directly matches the definition for Board/Management Information (MANG). Although it is an RNS filing, the specific nature of the announcement (Directorate Change) makes MANG the most precise classification.
2024-08-13 English
Grant of Options
Regulatory Filings Classification · 1% confidence The document is a formal announcement disseminated via RNS (RNS Number: 1845Z) on August 5, 2024. The content explicitly details the 'Grant of Options' over ordinary shares to an executive director (James Cooper, COO). This type of announcement, concerning insider transactions (granting of options to management), is typically classified under Director's Dealing (DIRS) or sometimes as a general Regulatory Filing (RNS). However, since the document specifically details transactions by a person discharging managerial responsibilities (PDMR) and is structured like a mandatory disclosure following the grant of options, it strongly aligns with the intent of insider transaction reporting. Given the specific definitions, 'Director's Dealing' (DIRS) is the most precise fit for reporting executive share/option transactions, although the structure also resembles a standard RNS announcement. Since the core subject is the grant of options to a director, DIRS is preferred over the general RNS fallback. The document is short and is an announcement, not the underlying detailed report itself.
2024-08-05 English
Final Results
Earnings Release Classification · 1% confidence The document is an 'Earnings Release' (ER) for Cambridge Nutritional Sciences PLC. It contains key financial highlights (revenue, EBITDA, operating loss, cash position) and operational highlights for the year ended 31 March 2024. It includes a Chair's Statement and a Chief Executive and Financial Review. While it provides detailed commentary, it functions as the initial announcement of the annual results, which is characteristic of an Earnings Release in the context of UK/AIM market filings. FY 2024
2024-07-25 English
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3192 characters) released via RNS (London Stock Exchange news service). The core content is the 'Notice of Results' stating that the company 'will announce the Group's Final Results for the year ended 31 March 2024 on Thursday 25 July 2024' and will follow up with an Investor Presentation. Since the document itself is not the full results (10-K or IR) but rather an announcement about *when* the results and presentation will occur, it fits the definition of a Report Publication Announcement (RPA). It announces the publication timing of other reports.
2024-07-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.